Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids (Q40585361)

21 September 2017

title

Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids (English)

1 reference

21 September 2017

Booth MJ

1

1 reference

21 September 2017

Mistry A

2

1 reference

21 September 2017

Li X

3

1 reference

21 September 2017

Thrasher A

4

1 reference

21 September 2017

Coffin RS

5

1 reference

21 September 2017

publication date

1 May 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

10

1 reference

21 September 2017

page(s)

829-837

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302226

21 September 2017

exact match

0 references

cites work

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Recombinant adeno-associated virus gene therapy for cystic fibrosis and alpha(1)-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Novel tools for production and purification of recombinant adenoassociated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Adeno-associated virus vectors can be efficiently produced without helper virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

High efficiency gene transfer to the central nervous system of rodents and primates using herpes virus vectors lacking functional ICP27 and ICP34.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Intratumoral gene therapy of malignant brain tumor in a rat model with angiostatin delivered by adeno-associated viral (AAV) vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Adeno-associated virus vectors for gene therapy: more pros than cons?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Rep-dependent initiation of adeno-associated virus type 2 DNA replication by a herpes simplex virus type 1 replication complex in a reconstituted system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Characterization of adeno-associated virus rep protein inhibition of adenovirus E2a gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

inferred from DOI database lookup

7 January 2021

based on heuristic

Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

inferred from DOI database lookup

7 January 2021

based on heuristic

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302226

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.GT.3302226

1 reference

Dimensions Publication ID

21 September 2017

1033913788

0 references

1 reference